(R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid

We are (R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid CAS:70785-61-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 70785-61-4
Product Name: (R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid
Other Name:
(R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid
2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid
 
Density: 1.4±0.1 g/cm3
Boiling Point: 696.8±55.0 °C at 760 mmHg
Molecular Formula: C15H14N2O5
Molecular Weight: 302.282
Flash Point: 375.2±31.5 °C
Exact Mass: 302.090271
PSA: 119.75000
LogP: 0.53
Vapour Pressure: 0.0±2.3 mmHg at 25°C
Index of Refraction: 1.662
 
Specification
Appearance: Off-white powder
Water: ≤1.0%
Specific rotation: -125.00°~-135.00°
Fe: ≤20ppm
Loss on drying: ≤1.5%
Single impurity: ≤0.5%
Assay: ≥98.0%
 
Application
Intermediates of Cefpiramide CAS: 70797-11-4.
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid


Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.90347-66-3 By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.cyclobutane-1,1-dicarboxylic acid Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.4-(4-chlorophenyl)piperidine-2,6-dione CAS:84803-46-3 International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.

Related Products
Product Name
2-(2H-Benzotriazol-2-yl)-p-cresol View Details
rac-1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile View Details
2-Fluoroethyl bromide View Details
Phenyltrichlorosilane manufacturer 4,4′-Dibromotriphenylamine manufacturer 2-Chloronitrobenzene manufacturer Z-Glu(OtBu)-OH manufacturer 2-Bromo-6-Methyl-3-Nitropyridine manufacturer